(firstQuint)A Single Dose Study Of PF-06291874 In Healthy Adult Subjects.

 The primary purpose of this trial is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06291874 in healthy volunteers.

 The trial was terminated on Jan 9, 2012, due to undesired pharmacokinetic properties.

 The decision to terminate the trial was not based on any safety or efficacy concerns.

.

 A Single Dose Study Of PF-06291874 In Healthy Adult Subjects@highlight

The primary purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06291874 in healthy volunteers.

